Skip to main content
. 2020 Oct 15;9(10):2295. doi: 10.3390/cells9102295

Figure 1.

Figure 1

The scheme depicts the pharmacological tools available to examine the therapeutic potential that exists in the field of PXR-mediated modification of breast cancer initiation, progression and metastases. We believe that this represents an important and exciting opportunity to move this field forward.